Press "Enter" to skip to content

ResCon1

No, Central Planning Did Not Help America to Win World War I, and It Won’t Help Us Win the War Against the Coronavirus

David Greenberg, a professor of history at Rutgers, has a piece in Politico today lauding the Progressive Era wartime economic planning of Woodrow Wilson.

Greenberg specifically credits the War Industries Board and a cluster of other federal agencies with marshaling the resources needed by the U.S. and its allies to win World War I.

More generally, he says the War Industries Board “helped vault the U.S. into its preeminent role in the world.”

If the War Industries Board failed to mobilize business as effectively as it might have, it did demonstrate clearly that only the government, and not the private sector, has both the authority and the size to direct and coordinate any industrial mobilization on a national scale.

Greenberg’s implication is clear:

President Trump needs to stop dragging his feet and use whatever federal powers might be necessary—including, but not limited to. invoking the Defense Production Act of 1950—to force General Motors and other big businesses to provide critically needed medical supplies to our hospitals and healthcare workers on the frontlines in the war against the coronavirus.

Greenberg is wrong. He is wrong about the history of the War Industries Board and central planning; he is wrong about the economics of the private sector versus central planning; and he is wrong about the public policy implications for today.

First the history and economics. America won World War I and became a preeminent world power in spite of President Woodrow Wilson’s “war socialism,” not because of it.

America, in fact, had been rapidly industrializing, and its economy growing, well before Wilson’s central planners began to gum up the works with their fascistic ideas of government control and coercion.

The Economic Historian Association’s Hugh Rockoff notes, for instance, that production of steel ingots and “total industrial production’—an index of steel, copper, rubber, petroleum, and so on”—was growing years before establishment (on July 28, 1917) of the War Industries Board. 

“It is evident,” Rockoff observes,

that the United States built up its capacity to turn out these basic raw materials during the years of U.S. neutrality when Britain and France were buying its supplies and the United States was beginning its own tentative build-up.

Moreover, despite their dangerously fascistic aspirations—and despite causing considerable economic mischief, damage, and dislocation by effectively discriminating against small-scale entrepreneurs who lacked political clout—the central planners at the War Industries Board were seriously hemmed in, and, as Greenberg himself admits, unable to implement their plans in full.

Their fascistic rhetoric far outpaced the reality of Wilson administration actions. 

In Greenberg’s view, this was precisely the problem. The War Industries Board “could cajole companies to act but had little ability to command them,” he writes.

In truth, though, the board’s limited power of command was our saving grace, and the very reason American industry was able to produce a vast amount of raw materials and munitions (aircraft especially) that proved decisive for the Allied war effort.

As historian Francis J. Munch succinctly put it in a 1973 review of Robert D. Cuff’s book, The War Industries Board: Business-Government Relations:

The WIB simply maintained the symbol and myth of an integrated system which in reality lay beyond its grasp. The agency was severely circumscribed by private interest groups, the military, and ideological assumptions of the mobilizers themselves…

The obstacles to wartime coordination and control (institutional factors and political conditions) were omnipresent…

In sum, the effectiveness of the WIB as a public symbol helped protect businessmen from traditional political pressure, while the ineffectiveness of the WIB as a bureaucratic power save them from undue intrusion by the state.

Greenberg also fails to mention that Wilson’s disastrous economic policies, rooted as they were in central planning and government control, led to “very high inflation… and a severe depression in his last year in office.

“[Indeed], industrial production,” writes economist Scott Sumner, “had fallen by 32.5% by March 1921,” when conservative Republican Warren G. Harding became president. Harding “cut income tax rates sharply” and the economy quickly recovered, surpassing its previous cyclical peak, Sumner notes.

As to the public policy implications for today, Greenberg insists that if Trump had used the Cold War-era Defense Production Act six weeks ago “to force General Motors to build the life-saving ventilators that are in short supply around the nation… those ventilators would probably be en route to hospitals today.”

No, that’s not true.

To be sure, Greenberg is right to fault Trump for being slow to recognize the magnitude of the danger presented by the coronavirus. Trump continually downplayed the problem when, in fact, he should have been rallying the nation to confront the problem.

That’s a fair and legit criticism, and one that we’ve made here at ResCon1.

And, truth be told, had Trump done so, it’s certainly the case that all Americans—private industry included—would have been more quick to recognize that we need many more masks, ventilators, respirators, and other crucial medical gear sooner rather than later.

But the question becomes means—or how, exactly, do we meet this unprecedented demand?

All of our historical experience, and everything that we know about economics, and the incontrovertible laws of supply and demand, tells us that far from the government needing to “command” or direct private-sector business decisions, we instead need to allow open and competitive markets to function and work.

Trump has been wildly inconsistent about whether he is or is not invoking the Defense Production Act to force General Motors to produce more ventilators.

One day he is throwing stones at GM and saying he will invoke the act; the next day he is saying that GM is being responsive and that invoking the act is unnecessary.

Regardless, one thing is crystal clear: private sector companies, including GM, are making heroic and herculean efforts to meet this unprecedented demand, and they are doing so irrespective of what Trump and the feds are or are not doing.

Why? Because they recognize that there is a severe need for this under-supplied medical gear, and they are rushing to meet that need, both to do good and to make money.

Price Signals. Greenberg echoes New York Governor Andrew Cuomo’s complaint that states are in a bidding war for ventilators; and that, therefore, the federal government needs to intervene to hold down prices.

But again, this betrays a serious lack of understanding of how markets work—and specifically, a lack of understanding of the importance of price signals as the means by which private sector producers identity and meet market demand.

As Alex Tabarrok, a professor of economics at George Mason University, explains at Marginal Revolution:

A price is a signal wrapped up in an incentive, as Tyler [Cowen] and I write in Modern Principles.

Compare the price system with command and control. We need ventilators. The federal government could order ventilator firms to make more but they are already doing so.

The government could order other firms to get into the ventilator business but does the federal government have a good idea which firms have the right technology, or which firms have the right technology that could be repurposed to ventilator production at low cost, that is without causing shortages and disruption in other fields?

Can they do better than a decentralized process in which millions of entrepreneurs respond to price signals. No.

Government’s Role. To be sure, this doesn’t mean that there isn’t a role for government in ensuring the prioritization and distribution of ventilators among the 50 states and regions.

Which is precisely, it seems, what former Clinton administration official Joshua Gotbaum is getting at when he argues, in the Washington Post, that Trump should involve the Defense Production Act.

“The act,” he writes, “allows federal agencies to collaborate with business to get critical supplies during emergencies—by encouraging investment and speeding production—and direct them to where they’re most needed [emphasis added].”

Okay, but prioritization and distribution of goods manufactured and produced by private sector companies responding to market signals is very different from the sort of state-run war planning scheme pushed by Greenberg as he harkens back to Woodrow Wilson’s War Industries Board.

Again, as Tabarrok explains:

If all the trucks are fleeing from the front, we want the army to be able to requisition vehicles to move in the opposite direction.

Private and social incentives do not always align and when time and certainty are of the essence command and control may be superior (as Tyler and I discuss in Modern Principles in the chapter on externalities).

For the most part, however, that is not the situation we are in now. Private incentives are all pushing in the right direction of greater production.

Let the market respond. The federal government is not good at command and control, but it does have a role to play in redistribution for need.

Bad History. In short, when it comes to history, “it ain’t what you don’t know that gets you into trouble. It’s what you know for sure that just ain’t so.”

Greenberg purports to know something that just ain’t so—to wit: that Progressive Era wartime economic planning by Woodrow Wilson and the War Industries Board was a great success—or at least a template or model that future American presidents should learn from and adapt to present circumstances.

In truth, the government’s attempt to commandeer and command private industry was misguided to begin with; it caused considerable economic mischief, damage, and dislocation; and America succeeded in spite of it, not because of it.

And it is a mistake we should not repeat any time soon, at least not if we wish to defeat the coronavirus and save American lives.

Feature photo credit: Woodrow Wilson, arguably the worst president in American history, courtesy of History.com.

A Lesson in Left-Wing Media Bias: the NYT Obits of Sen. Tom Coburn and Fidel Castro

The media lean overwhelmingly to the left. This should be obvious to anyone who is a serious consumer of news and information. But here’s a very timely and illustrative example of this bias, courtesy of eagle-eyed John Tabin.

It concerns the New York Times’ coverage of former Sen. Tom Coburn (R-Oklahoma), a highly principled conservative who, sadly, passed away Saturday at the age of 72 due to complications with prostate cancer.

Coburn was always “direct, thoughtful, and principled,” tweets Washington Examiner executive editor Philip Klein. “He will be sorely missed. RIP.”

He “was one of the finest public servants of my lifetime,” adds Klein’s colleague, Washington Examiner columnist Quin Hillyer:

[A] practicing obstetrician, [Coburn] combined fierce devotion to principle with rigorous intellectual integrity and tremendous personal decency.

One of the most hard-line conservatives in first the House and then the Senate, he nonetheless enjoyed the respect and friendship of many liberal Democrats.

Not the least of these was President Barack Obama, with whom he reportedly spoke in private, as a friend and sounding board, almost weekly throughout Obama’s White House tenure…

When Coburn arrived on Capitol Hill in the “Gingrich Revolution” Republican class of 1994, he was an unyielding ideologue.

Even then, though, there was a difference: Whereas some super-hard-liners are full of sound and fury without much thoughtfulness, Coburn obviously had depth and intellect…

Rather than being a gadfly, Coburn became an effective leader, without ever doing the “go-along to get-along” kind of games.

He began publishing an annual Wastebook highlighting absurd government spending and also a weekly “pork report” listing egregious examples of wasteful projects from almost every federal agency.

He took the lead in opposing Obamacare while pushing real healthcare reforms of a conservative variety, some of which have gone into law piecemeal over the years even without passage in a single, comprehensive bill.

And, often working with Democrats, he became a leader in providing effective congressional oversight and insisting that government operate with public transparency.

As Democratic Sen. Carl Levin of Michigan put it, Coburn was “tough, fearless, and more interested in facts than politics.”

Yet, the lead sentence of the New York Times obituary of Coburn describes him as an “ultraconservative” “crusader” and legislative obstructionist whom “frustrated legislators” called “Dr. No.”

In other words, Coburn wasn’t a very pleasant fellow. He was ornery and disagreeable, and he was always blocking and obstructing legislative progress. Boo!

By contrast, the lead sentence of the New York Times obituary of Cuban dictator Fidel Castro describes him as

the fiery apostle of revolution who brought the Cold War to the Western Hemisphere in 1959 and then defied the United States for nearly half a century as Cuba’s maximum leader, bedeviling 11 American presidents and briefly pushing the world to the brink of nuclear war, died on Friday. 

The Times’ obit is accompanied by a glamorous photo of Fidel smoking a cigar and looking cool, thoughtful, and contemplative. Castro must have been an interesting and colorful character! the reader is lead to believe.

I mean, who is this “fiery apostle of revolution” who, almost miraculously, outfoxed the United States decade after decade?!

In fact, Castro was a sadistic dictator who authorized the murder of tens of thousands of Cubans, while forcing the island into a decades-long immiseration that continues to this day.

People streamed out of the country, if they were able,” recalled National Review

Over the years of the Castro regime, one million Cubans have gone into exile. Some Cubans have been shot in the water, in their attempts to flee.

On one day—July 13, 1994—there was an infamous massacre, the Tugboat Massacre: Castro’s forces killed 37 would-be escapees, most of them children and their mothers.

What kind of regime does this? What kind of regime would rather kill people, in cold blood, than see them leave? Than see them have a free life?

The Castro regime, and it has been very popular, though not in Cuba.

This is how the media’s left-wing bias works. It’s not that they report outright lies and falsehoods, or blatantly “fake news.” That would be too egregious and noticeable.

Instead, it is that they use language and prose that shows real sympathy, understanding, and indulgence toward political figures on the left, but considerable skepticism and hostility toward political figures on the right.

And that is how and why the New York Times—one of the greatest newspapers in history and one of the greatest newspapers still even today—can write admiringly of a vicious tyrant like Fidel Castro, while writing critically of a dedicated family man and patriot like Tom Coburn.

Don’t call it fake news. Call it twisted and distorted news.

Feature post credit: Poynter.

Tests, Vaccines, and Medical Supplies: America Mobilizes to Combat the Coronavirus

Because the entrepreneurial spirit and rebellion against authority are part and parcel of our national and cultural DNA, you can never say America is down for the count.

Sure, things look bad right now; but it’s always darkest before the dawn. And Americans are not standing idly by and passively accepting their dire fate as predicted by the “experts.” Instead, they’re fighting back, and with notable, if underplayed and unheralded, success.

For example, Abbott Labs announced Friday that it has developed a new, portable test that can determine, within five to 13 minutes, whether someone is infected with the coronavirus.

The company expects to deliver 50,000 tests per day starting next week.

Scott Gottlieb, former head of the Food and Drug Administration (FDA), and a medical doctor who has been at the forefront of assessing the COVID-19 pandemic, calls the new test a “game-changer.” He says it’s very likely that other Point of Care diagnostic tests will soon be coming to market.

Point of Care testing is medical testing that can be done anywhere and not just in a hospital or laboratory setting.

Point of Care testing is critically important because it will facilitate rapid and comprehensive testing, which is integral to mitigation and containment strategies that will break the epidemic spread of the virus and allow Americans to return to work.

“If we know who is infected, who is not, and who has recovered, we could greatly relax social isolation requirements and send both the uninfected and the recovered back to work,” explain researchers Tim Searchinger, Anthony LaMantia, and Gordon Douglas.

Indeed, only “massive testing” of the entire U.S. population will allow us to avert “two disastrous and unsustainable scenarios,” they argue.

The first scenario involves essentially shutting down the U.S. economy for perhaps a year or more until a vaccine is developed.

The second scenario involves shutting down the U.S. economy (or major parts of the U.S. economy) intermittently in response to each new outbreak of the virus.

In either scenario, the result would be a severe recession, if not a great depression. And, “even with intermittent isolation,” write the researchers, hospitals likely “would be overwhelmed and many people would die.”

Thus says Gottlieb: “We need widespread testing to know where and to what extent the virus is spreading.”

Physicians, meanwhile, are making innovative, “off-label” use of hydroxychloroquine (an anti-malarial drug) and azithromycin (an antibiotic) to treat COVID-19 patients, and with promising results.

Medical researchers, likewise, are working round-the-clock to develop a vaccine, as clinical trials are underway and moving apace

“America is home to a vast, dynamic life-science industry,” says Gottlieb. “This is its moment. This is why decades of drug investment and development matter so much.”

The “arsenal of democracy,” moreover, is rapidly retooling to become the healthcare supplier of first resort.

Ventec Life Systems and General Motors, for instance, have teamed up to meet an urgent and unprecedented need for “FDA-cleared Level 1 surgical masks” and “sophisticated, high-quality critical care ventilators.”

“The companies are adding thousands of units of new capacity with a significantly expanded supply chain capable of supporting high volume production. GM is contributing its resources at cost,” the companies announced Friday.

Make no mistake: America was slow to realize the dangers of the coronavirus. We were caught flatfooted and unprepared. We did not realize what was hitting us.

But as Churchill famously said, “You can always count on the Americans to do the right thing—after they’ve tried everything else.”

We may not have tried everything else, but we’re certainly doing the right thing—or at least trying mightily to do the right thing. And that matters. That is why America is not yet done. Not by a long shot.

Feature photo credit: Abbott Labs in Temecula, California via Connect Media.

Trump Is Right About Cuomo’s Failure to Procure Ventilators, and the So-Called Fact Checkers Are Wrong

As we reported here at ResCon1, Tuesday, March 24, New York’s Democratic Governor, Andrew Cuomo, bears significant responsibility for his state’s lack of ventilators.

U.S. intelligence agencies and public health experts, we observed, warned Cuomo and other government officials years ago of likely pandemics that would overburden our hospitals and healthcare system.

A New York state task force, in fact, specifically warned Cuomo of the lack of ventilators during a pandemic. Cuomo, though, opted not to purchase the requisite number of ventilators.

These are all facts, not opinion or conjecture, and this a matter of public record.

What is a a matter of opinion is Cuomo’s assertion that Trump needs to “nationalize” the medical supply chain, because doing so would mean that 30,000 ventilators would suddenly be produced and descend upon New York State hospitals.

Trump, as we reported here at ResCon1, has wisely resisted Cuomo’s call to have the federal government take over the medical supply chain, because doing so would not solve anything.

Instead, nationalization would create more problems because the government is inept at running commercial businesses. That is simply not a public-sector comparative advantage. 

Trump, meanwhile, hit back against Cuomo in a Fox News virtual town hall:

This [article] says that New York Governor Cuomo rejected buying recommended 16,000 ventilators in 2015 for the pandemic—for a pandemic; established death panels and a lotteries instead.

So he had a chance to buy, in 2015, 16,000 ventilators at a very low price and he turned it down.

I’m not blaming him or anything else, but he shouldn’t be talking about us. He’s supposed to be buying his own ventilators. We’re going to help.

But, you know, if you think about—if you think about Governor Cuomo, we’re building him four hospitals. We’re building him four medical centers.

We’re working very, very hard for the people of New York. We’re working along with him, and then I watch him on the show, complaining. And he had 16,000 ventilators that he could have had at a great price and he didn’t buy them.

As a result of these comments, two news organizations, The Dispatch and FactCheck.Org, have published overly long, tendentious, and convoluted criticisms of Trump for allegedly not telling the truth about Cuomo and the ventilators. But their criticisms really miss the mark and are beside the point.

FactCheck.Org flags Trump for charging that, because New York failed to purchase more ventilators years ago, it would be forced to employ a “lottery system” and “death panels” to ration the use of available ventilators. This is “misleading,” they argue.

Moreover, says FactCheck.Org, the New York State task force that looked into the matter in 2015 “did not recommend whether the state should buy more ventilators (and hire the staff necessary to operate them).”

But this is splitting hairs. As Betsy McCaughey explains in the New York Post,

In 2015, that task force came up with rules that will be imposed when ventilators run short.

Patients assigned a red code will have highest access, and other ­patients will be assigned green, yellow or blue (the worst), ­depending on a “triage officer’s” decision.

In truth, a death officer. Let’s not sugar-coat it. It won’t be up to your own doctor.

Exactly. Let’s not sugar-coat it. As for the reference to a “lottery system,” that came from a Feb. 27, 2020, New York Times article:

The task force that issued the report devised a formula, relying partially on medical criteria, to help hospitals decide who would get ventilators and who would not.

It also envisioned a lottery system in some instances. And age could play a role, with children being given preference over adults.

Rationing. But the larger-scale point, which we made here at ResCon1 is this: without more ventilators soon, ventilators will have to be rationed, and that means deciding who will live and who will die.

Call it what you will, that is a problem—a big and serious problem. 

And whether the task force recommended that the state buy more ventilators is immaterial. The reality is that, as Governor of New York State, Cuomo has a responsibility to safeguard the health and safety of his people, the residents of New York. He failed.

He failed by not buying more ventilators—even though he had been warned of this problem, and even though he had been warned about the likelihood of a pandemic that would require many more ventilators. 

Maybe he failed for good reason: because the tradeoffs were too difficult and too stark. Still, he failed. As governor, the buck stops with him.

The Dispatch, meanwhile, complains that “Trump provided no evidence to support his claim that Cuomo could have had the ventilators ‘at a very low price’ in 2015, and that Cuomo ‘turned it down.’”

But cost, too, is really immaterial. When it comes to public health, government has an obligation to spend whatever it takes to protect the health and well-being of their people—us.

That is a fundamental and non-negotiable obligation of the state.If government officials think the cost of public health is too high or prohibitive, then they should say so, clearly and publicly.

That way, we can openly and rationally discuss and debate the tradeoffs involved, our public policy and spending priorities, and what level of risk we, as a society, are willing to assume.

In any case, Trump was echoing what McCaughey argued in her New York Post piece. “In 2015,” she wrote,

the state could have purchased the additional 16,000 needed ventilators for $36,000 a piece, or a total of $576 million. It’s a lot of money, but in hindsight, spending half a percent of the budget to prepare for a pandemic was the right thing to do.

The Dispatch also gets lost in the weeds on the origins of the New York State task force and its precise findings; but this is all background noise and beside the point.

The bottom line is this: Cuomo was warned of a problem and yet, he did not act.

But what’s done is done. What matters now is: where do we go from here? How do we ramp up production and delivery of ventilators to New York and other states that are suffering most from the coronavirus?

The most obvious place to begin is with the Strategic National Stockpile, “the government reserve meant to fortify overwhelmed hospitals in a crisis.” But that stockpile has only 16,600 ventilators, reports the Center for Public Integrity—far fewer than the 64,000 to 742,000 that might be needed.

In truth, only an unleashed and unchained private sector free to innovate can possibly produce the requisite number of ventilators quickly enough to meet the anticipated demand. Fortunately the Trump administration is relaxing the regulatory burden and companies are stepping up to produce.

A company called Prisma Health, for instance, is using 3D printing to manufacture a new ventilator model that can support up to four patients simultaneously.

The company says that it “has received emergency use authorization” from the Food and Drug Administration (FDA) and is working with “COVID-19 [treatment] teams who have no more ventilator capacity, and who can initiate emergency use of the prototype.”

The good news, reports the Wall Street Journal’s William McGurn, “is that players in the private sector… have already been in touch with one another to see how they might team up.”

For example, he writes, before the coronavirus hit, one company’s “peak output was roughly 150 ventilators a month.” However, within the next 90 days, they expect to increase that to 1,000 ventilators a month.

“It won’t be easy [nor will it happen] overnight,” says Chris Kiple, “but it can be done.”

Mr. Kiple is CEO of Seattle-based Ventec Life Systems. He says Ventec is one of about a dozen players in the global market for ventilators, only about half of which are U.S.-based companies.

“Ventec,” McGurn writes, recently

announced it will work in partnership with General Motors. The idea is to combine GM’s experience of mass-production manufacturing with Ventec’s technology.

Mr. Kiple says the partnership will mean getting “more ventilators to more hospitals much faster.” The president tweeted Sunday, [March 22, 2020]: “Go for it auto execs.”

Feature photo credit: NY1

J-L Cauvin Does the Greatest Impersonation of Donald Trump That You’ve Ever Seen—and Heard!

Thanks to Twitter, I stumbled upon this wonderfully entertaining and amazingly spot-on impersonation of Donald Trump. The gentleman’s name is

J-L Cauvin. As you can see, he is an extraordinary talent.

https://twitter.com/JLCauvin/status/1242515702688485376

What makes Cauvin’s impersonation of Trump so compelling, I think, are three things, three rare gifts that he has:

First, like all great impressionists, Cauvin captures his subject’s voice and inflections to a tee. Indeed, the timbre and intonation of his voice all truly sound like Trump’s. It is remarkable. Cauvin obviously has a great ear.

Second, Cauvin perfectly captures Trump’s facial expressions, contortions, and mannerisms. It is, amazingly, like watching The Donald.

Third, Cauvin is a great writer. He not only looks and sounds like Trump; he speaks like Trump! Thus he perfectly captures Trump’s rhetorical tics and unique style of speaking.

Cauvin’s satirical spoof on Trump’s Easter message (above) is pure brilliance and a joy to behold. In fact, Cauvin is so good that I cannot help but wonder: why has he not received greater national attention?

For example, why has he not been on Saturday Night Live? Cauvin is much more entertaining than Alec Baldwin, who does a very weak and decidedly unentertaining Donald Trump.

The reason may be that Cauvin is too good. He is laugh-aloud entertaining, and his impersonation has the effect of humanizing Trump. And humanizing Trump is the very last thing our progressive denizens of pop culture want to do.

Trump, to them, is a monster, and he must be depicted as such.

It’s too bad because wit and humor can help soften and leaven the political polarization that plagues our country.

But even were that not the case, there is intrinsic wisdom and beauty in great art that is worth contemplating for its own sake. And great art should be considered as such irrespective of the subject whom it depicts.

All of which is to say: Donald Trump may a less-than-admirable human being; but J-L Cauvin’s depiction of Trump is, nonetheless, admirable and impressive—and well worth the moments of levity that it engenders.